Keywords
practices
pregnant women
hepatitis B
How to Cite
Abstract
Introduction :
the vertical transmission of Hepatitis B is responsible for more than a third of contamination in areas of high endemicity. The objective of this work was to study the knowledge and practices of pregnant women seen in prenatal consultations with regard to hepatitis B at the Lanquinitinie Hospital in Douala.
Materials and methods :
the cross-sectional study was carried out from 1 May to 1 December 2019. Two hundred consenting pregnant women were included. The diagnosis of hepatitis B was made by the detection of the HBs antigen by the ELISA method. Data were collected by face-to-face interviews on the basis of a questionnaire and then supplemented by patient records. The data analysis was done by the SPSS 20.0 software.
Results :
the prevalence of hepatitis B was estimated at 9%. The age of the women ranged from 13 to 45 years with an average of 29.17 years (±5.75), of which 18% were over 34 years old. Women with higher levels of education accounted for 47 per cent, and 49 per cent were married. In 40.5% of women, the mode of transmission was unprotected sex and blood transfusion for 18%; 88.5% were aware of mother-to-child transmission and 79% were aware of the existence of the hepatitis B vaccine. The number of partners was multiple for 7%, in 2% of cases the sexual habit was anal and 24.5% were vaccinated against hepatitis B virus.
Conclusion :
knowledge about hepatitis B virus infection and how it is transmitted by women is satisfactory. However, the challenge is adherence to prevention through vaccination against hepatitis B virus.
References
1. ONUSIDA, Rapport mondial d’avancement sur la lutte contre le sida 2017. Consulté le 28 Décembre 2023. Disponibe sur : http://aidsreportingtool.unaids.org
2. Ojide CK, Kalu EI, Ogbaini-Emevon E, Nwadike VU. Co-infections of hepatitis B and C with human immunodeficiency virus among adult patients attending human immunodeficiency virus outpatient’s clinic in Benin City, Nigeria. Nigerian Journal of Clinical Practice. 2015 ; Vol 18 (4) :516-521 doi : 104103/1119-3077.151790.
3. Organisation mondiale de la Santé. Rapport mondial sur l´hépatite : résumé d'orientation. 2017. Consulté le 4 janvier 2024. Disponible sur : https://iris.who.int/handle/10665/255833
4. Isa I, Aminu M, Abdullahi SA, Sani MA, Usman MA, Esona MD, Ella EE. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Infection among Students in Ahmadu Bello University, Zaria, Nigeria. Arch Med Biomed Res. 2017; 3:77-90 doi:10.4314/ambr.v3i2.4.
5. Kye-Duodu G, Nortey P, Malm K, Nyarko KM, Sackey SO, Ofori S et al. Prevalence of hepatitis B virus co-infection among HIVseropositive persons attending antiretroviral clinics in the Eastern Region of Ghana. The Pan African Medical Journal. 2016; 25 (1):7. doi: 10.11604/pamj.supp.2016.25.1.6172.
6. Ministère de la Santé Publique du Cameroun, Centre Pasteur du Cameroun. Les virus des hépatites et autres virus oncogènes [en ligne] disponible sur https://www.pasteur-network.org. Consulté le 28 décembre 2023.
7. Adegbesan-Omilabu MA, Okunade KS, Gbadegesin A, Olowoselu OF, Oluwole AA, Omilabu SA. Seroprevalence of hepatitis B virus infection among pregnant women at the antenatal booking clinic of a tertiary hospital in Lagos Nigeria. Nigerian Journal of Clinical Practice. 2015;18 (6): 819-823. doi: 10 4103/1119-3077.163283.
8. Völker F, Cooper P, Bader O, Uy A, Zimmermann O, Luger R and al. Prevalence of pregnancy-relevant infections in a rural setting of Ghana. BMC Pregnancy Childbirth. 2017 ;17(1): 1-7. doi:10.1186/s12884-017-1351-3.
9. Bochardt SM, Kocharian A, Hopfensperger D, Davis JP. Prevention of perinatal transmission of hepatitis B virus: assessment among Wisconsin Maternity Hospitals. WMJ. 2016; 115(2):74-80.
10. Kim HY, Choi JY, Park CH, Jang JW, Kim CV, Bae SH et al. Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus. J Clin Virol. 2013; 56(4) :299-305. doi: 10.1016/j.jcv.2012.11.019.
11. Frambo AA, Atashili J, Fon PN, Ndumbe PM. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study. BMC Research Notes. 2014; 7: 394 doi: 10.1186/1756-05800-7-394.
12. Noubiap N, Nansseu N, Shalom TN, Bigna R, Jingi M, Fokom-Domgue J. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon. BMC Public Health. 2015;15: 454. doi: 10.1186/s12889-015-1806-2.
13. Loriette M, Birguel J, Damza R, Ratoua M, Karsikam S, Sobnangou JJ et al. Une expérience de lutte contre l´hépatite B en zone rurale à l´extrême nord du Cameroun. Médecine et Santé Tropicales 2015; 25(4): 422-27. doi : 10.1684/mst.2015.0507.
14. Wu S, Wang J, Guo Q, Lan H, Sun Y, Ren M, et al. Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2023 Aug;29(8):1000-1007. doi: 10.1016/j.cmi.2023.03.002. Consulté le 14 Juillet 2024.
15. Njoya O. Essi MJ, Ongolo B, Obama MT. Connaissances, Perceptions et Pratiques des Femmes Enceintes Vis-à-vis de l’Hépatite Virale B en Milieu Urbain au Cameroun. Health Sci. Dis. 2013, Vol 14 (2): 1-4 doi: 10.5281/hsd.v14i2.149.
16. Nsiah I, Danquah CB, Odame Anto E, Obirikorang C, Owiredu WKB, Acheampong E et al. Factors associated with knowledge, attitude and practice towards hepatitis B infection among pregnant women attending antenatal clinic in the Kumasi Metropolis, Ghana: a multicentre hospital based cross-sectional study PAMJ - One Health. 2020;2(24). doi: 10.11604/pamj-oh.2020.2.24.24716. Consulté le 14 juillet 2024
17. Ade-Ojo IP, Babatola AO, Ojo TO, Ogundare EO, Agbesanwa T, Adeniyi AT et al. Knowledge and Willingness to Utilize Hepatitis B Preventive Measures among Pregnant Women in Ado-Ekiti, Southwest, Nigeria. Interdiscip Perspect Infect Dis. 2023 Nov 16; 2023 (4): 1-10 doi: 10.1155/2023/9168038.
18. Abongwa LE, Kenneth P. Assessing prevalence and risk factors of hepatitis B surface antigen amongst pregnant women attending antenatal clinic in the northwest region of Cameroon. European Journal of Research in Medical Sciences. 2016;4(1): 32-43.
19. Mohamed R, Ng CJ, Tong WT, Abidin SZ, Wong LP, Low WY. Knowledge, attitudes and practices among people with chronic hepatitis B attending a hepatology clinic in Malaysia: A cross sectional study. BMC Public Health. 2012; 12:601. doi:10.1186/1471-2458-12-601.
20. Umare A, Berhanu S, Tesfaye G,Tamirat HM. Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia. PloS one. 2016;11(11): e0166936 doi: 10.1371/journal.pone.01666936.
21. Kirbak ALS, Ng’ang’a Z, Omolo J, Idris H, Usman A, Mbabazi WB. Sero-prevalence for Hepatitis B virus among pregnant women attending antenatal clinic in Juba Teaching Hospital, Republic of South Sudan. The Pan African Medical Journal. 2017 ;26 :72 doi: 10.11604/pamj.2017.26.72.11410 Consulté le 15 janvier 2024.
22. Ali FK, Ali HA, Araby OAW. Pregnant Women' Knowledge and Attitude regarding Hepatitis BVirus Infection: a Structured Teaching Program. Egyptian Journal of Health Care. 2021 Vol. 12 No. 1:301-324. doi: 10.21608/EJHC.2021.140546 Consulté le 14 Juillet 2024
23. Hannachi N, Bohri O, Mhalla M, Marzouk A, Sadraoui A, Belguith H et al. Hépatite virale B chez les femmes enceintes tunisiennes : facteurs de risque et intérêt de l’étude de la réplication virale en cas d’antigène HBe négatif. Pathologie biologie. 2009 ; vol 57 (3) : 43-47. doi :10.1016/j.patbio.2008.04.017 Consulté le 4 mars 2024
Metrics
Downloads
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Z Ali, A Linjouom, S Moussa Saley, H Ali, L Makhtar Mbacké